Evidence map›Paper›PMID 42819612›Full record

ReviewComputational and structural biotechnology journal2026

Machine Learning in Stem Cell Research: From Biological Data to Clinical Translation.

Anna Nicolaou, Yan Hong, Delong Zhou, Geovanni Geukgeuzian, Vasisht Yegneshwaran, Nehal Kamal Ali, Diego Fraidenraich, Xueqing Huang

Abstract readReview
In one paragraph

Review in Computational and structural biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anna NicolaouDepartment of Computer Science, New York Institute of Technology, Old Westbury, NY 11568, USA.ORCID https://orcid.org/0009-0008-4165-5026
Yan HongDepartment of Computer Science, New York Institute of Technology, Old Westbury, NY 11568, USA.ORCID https://orcid.org/0009-0003-2568-9078
Delong ZhouDepartment of Cell Biology & Molecular Medicine, Rutgers New Jersey Medical School, Newark, NJ 07101, USA.ORCID https://orcid.org/0000-0002-4427-0008
Geovanni GeukgeuzianDepartment of Cell Biology & Molecular Medicine, Rutgers New Jersey Medical School, Newark, NJ 07101, USA.ORCID https://orcid.org/0000-0002-7949-5549
Vasisht YegneshwaranDepartment of Cell Biology & Molecular Medicine, Rutgers New Jersey Medical School, Newark, NJ 07101, USA.ORCID https://orcid.org/0000-0001-7501-9564
Nehal Kamal AliDepartment of Cell Biology & Molecular Medicine, Rutgers New Jersey Medical School, Newark, NJ 07101, USA.ORCID https://orcid.org/0000-0002-3922-8104
Diego FraidenraichDepartment of Cell Biology & Molecular Medicine, Rutgers New Jersey Medical School, Newark, NJ 07101, USA.ORCID https://orcid.org/0000-0001-5369-4446
Xueqing HuangDepartment of Computer Science, New York Institute of Technology, Old Westbury, NY 11568, USA.ORCID https://orcid.org/0000-0002-3677-5946

Funding

Connexin 43: a new player in Duchenne muscular dystrophy associated cardiomyopathyR01HL171094 · NHLBI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI DIEGO FRAIDENRAICH · 2024 to 2026
$2.0M
NHLBI NIH HHS R01 HL171094
6 · The paper itself

Abstract

Stem cell (SC) research plays a central role in disease modeling and regenerative medicine, yet its clinical translation remains challenged by biological heterogeneity, incomplete cellular maturation, stringent quality-control requirements, and increasingly complex biological and clinical data. Machine learning (ML) has emerged as a powerful computational approach for extracting biologically meaningful information from these data, enabling quantitative characterization of SC behavior and predictive modeling across diverse experimental and translational applications. This review presents a unified framework for ML in SC research by organizing the literature according to SC data sources and representations, ML methodologies and model families, and biological and clinical application domains. We review ML applications spanning SC reprogramming, differentiation, postdifferentiation maturation, quality control, disease modeling, therapeutic development, and clinical decision support, highlighting how diverse experimental data, including molecular and cellular profiling, biomedical imaging, biochemical profiling, functional measurements, and clinical data, enable biological interpretation, predictive modeling, and translational decision-making. We further discuss benchmark dataset selection, validation strategies, transformer-based foundation models, and emerging multimodal learning approaches and propose benchmark dataset selection criteria emphasizing biological diversity, experimental rigor, metadata completeness, reproducibility, and public accessibility. Collectively, this review provides a comprehensive framework for understanding current ML applications in SC research and outlines future directions toward robust, interpretable, and clinically translatable computational frameworks.

Identifiers

PMID42819612
PMCPMC13624364

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.